"Formosa Pharma welcomes this partnership with Cipla, a well-renowned and respected global pharmaceutical brand. We appreciate their recognition and desire to add APP13007 to their rich portfolio ...

Cipla's EBITDA for the quarter rose by 15.7 per cent YoY to Rs 1,989 crore, while the EBITDA margin improved by 184 basis points to 28.1 per cent. The company said its sustained margins were a result ...

Cipla shares gained over 2 percent on December 17 after Kotak Institutional Equities upgraded the stock to a 'buy' from its previous 'add' rating. The upgrade was driven by factors such as ...

Drugmaker Cipla has got regulatory approval to market Afrezza, a rapid acting insulin delivered through an inhaler, as compared to other insulins given through injections. The Central Drugs ...

Cipla share price fell the most in terms of percentage among all the 50 companies in the NSE Nifty today Cipla share price: Cipla Ltd shares fell the most in terms of percentage among all the 50 ...

Drugmaker Cipla continues to struggle with regulatory challenges which have caused delays in the launch of two key drugs--respiratory medication Advair and chemotherapy drug Abraxane- yet again.

Oct 29 (Reuters) - Cipla (CIPL.NS), opens new tab, India's third-largest generic drugmaker by sales, reported a 15.2% rise in second-quarter profit that beat estimates, driven by higher sales of ...

Cipla Health Limited is wholly-owned subsidiary of Cipla (Image Credits: PTI) Cipla Limited on Monday received approval from the Central Drugs Standard Control Organization (CDSCO) to market the ...

Indian pharmaceutical firm Cipla is sharpening its aim to become a leader in respiratory medications in the United States. During its third quarter earnings conference call, Cipla's management ...

New Delhi: Pharmaceutical major Cipla Ltd has invested ₹42 crore in GoApptiv, increasing its stake in the digital tech company to 22.99% on a diluted basis. “In line with Cipla’s ambition to ...

Cipla USFDA news: Cipla said there was no new development requiring additional disclosure on the matter. The sharp fall in Cipla shares on Thursday was triggered by concerns about whether the warning ...

Drugmaker Cipla is set to acquire South Africa’s Actor Holdings (Pty) Ltd for $48.6 million (about ₹402 crore), strengthening its over-the-counter (OTC) products portfolio. The transaction w ...